Interest-bearing debt
Pass2.3%of market cap
0%limit 30%
Filed balance sheet (Form 10-Q, period ending 2026-06-30)
AXSMNasdaq
Healthcare · Pharmaceuticals
Verdict
Passes the business-activity screen and all three AAOIFI financial tests, each from Axsome Therapeutics Inc's own filings.
AAOIFI Shari'ah Standard No. 21 · screened 15 Oct 2026
Each bar shows the figure against its limit; the line marks the limit.
2.3%of market cap
Filed balance sheet (Form 10-Q, period ending 2026-06-30)
3.7%of market cap
Filed financial statements
1.0%of revenue
No prohibited activity (alcohol, gambling, tobacco, conventional finance, pork, adult content) found in the sector, SEC industry or company name.
We couldn’t load historical prices for AXSM just now — most often our data provider is briefly rate-limited and a retry in a minute succeeds. If it keeps happening, the symbol may be outside our chart coverage or recently IPO’d. Hero price, fundamentals, and Shariah screening on this page are unaffected.
See the business + financial screening, dividend purification ratio, and category-by-category compliance status.
Upgrade to ProFiled financial statements